These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3000959)

  • 21. Evaluation of drug abuse rehabilitation efforts: a review.
    Quinones MA; Doyle KM; Sheffet A; Louria DB
    Am J Public Health; 1979 Nov; 69(11):1164-9. PubMed ID: 507249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Politicians and scientists in the combat against drug abuse.
    Gunne LM
    Drug Alcohol Depend; 1990 Apr; 25(2):241-4. PubMed ID: 2328660
    [No Abstract]   [Full Text] [Related]  

  • 23. Counselor incentives to improve client retention in an outpatient substance abuse aftercare program.
    Shepard DS; Calabro JA; Love CT; McKay JR; Tetreault J; Yeom HS
    Adm Policy Ment Health; 2006 Nov; 33(6):629-35. PubMed ID: 16758330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of time in drug abuse treatment and employment on posttreatment drug use and criminal activity.
    French MT; Zarkin GA; Hubbard RL; Rachal JV
    Am J Drug Alcohol Abuse; 1993; 19(1):19-33. PubMed ID: 8382448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Making residential treatment available to methadone clients.
    Zweben JE; Aly T; Martin J; Wengrofsky S; Bacci J; Meddaugh R
    J Subst Abuse Treat; 1999 Oct; 17(3):249-56. PubMed ID: 10531632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating combined alcohol and drug abuse in community-based programs.
    Hubbard RL
    Recent Dev Alcohol; 1990; 8():273-83. PubMed ID: 2185522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment services in two national studies of community-based drug abuse treatment programs.
    Etheridge RM; Craddock SG; Dunteman GH; Hubbard RL
    J Subst Abuse; 1995; 7(1):9-26. PubMed ID: 7655314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of counseling rapport and topics discussed in sessions with methadone treatment clients.
    Joe GW; Simpson DD; Rowan-Szal GA
    Subst Use Misuse; 2009; 44(1):3-17. PubMed ID: 19137479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-year follow-up of opioid addicts after admission to treatment.
    Simpson DD; Joe GW; Bracy SA
    Arch Gen Psychiatry; 1982 Nov; 39(11):1318-23. PubMed ID: 6982696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desipramine treatment of cocaine abuse in methadone maintenance patients.
    Arndt I; Dorozynsky L; Woody G; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1989; 95():322-3. PubMed ID: 2701300
    [No Abstract]   [Full Text] [Related]  

  • 33. The perceptions of program directors and clients regarding the efficacy of methadone treatment.
    Mavis BE; DeVoss GH; Stöffelmayr BE
    Int J Addict; 1991 Jul; 26(7):769-76. PubMed ID: 1660042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A substance-abuse research-treatment clinic: effective procedures and systems.
    Elk R; Grabowski J; Rhoades H; McLellan AT
    J Subst Abuse Treat; 1993; 10(5):459-71. PubMed ID: 8246321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Client well-being in drug treatment: a social ecological analysis.
    Ruffing-Rahal MA
    Int J Addict; 1985 Sep; 20(9):1305-20. PubMed ID: 4077327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Rieckmann T; Daley M; Fuller BE; Thomas CP; McCarty D
    J Subst Abuse Treat; 2007 Mar; 32(2):207-15. PubMed ID: 17306729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between drug treatment services, retention, and outcomes.
    Hser YI; Evans E; Huang D; Anglin DM
    Psychiatr Serv; 2004 Jul; 55(7):767-74. PubMed ID: 15232015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in chemotherapy of narcotic addiction. Part VII. Evaluation of present treatment modalities: research with DARP admissions, 1969-1973.
    Sells SB; Demaree RG; Simpson DD; Joe GW
    Ann N Y Acad Sci; 1978; 311():270-81. PubMed ID: 217292
    [No Abstract]   [Full Text] [Related]  

  • 40. Financing and cost of standard and enhanced methadone treatment.
    Bradley CJ; French MT; Rachal JV
    J Subst Abuse Treat; 1994; 11(5):433-42. PubMed ID: 7869464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.